ArticleRespiratory medicine case reports2021

Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.

Masao Takemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.